Lysophosphatidic Acid May Be a Novel Biomarker for Early Acute Aortic Dissection

Lysophosphatidic Acid May Be a Novel Biomarker for Early Acute Aortic Dissection

Background: Misdiagnosis and delayed diagnosis of acute aortic dissection (AAD) significantly increase mortality. Lysophosphatidic acid (LPA) is a biomarker related to coagulation cascade and cardiovascular-injury. The extent of LPA elevation in AAD and whether it can discriminate sudden-onset of ac...

Full description

Bibliographic Details
Main Authors: Xiaogao Pan, Yang Zhou, Guifang Yang, Zhibiao He, Hongliang Zhang, Zhenyu Peng, Wen Peng, Tuo Guo, Mengping Zeng, Ning Ding, Xiangping Chai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Surgery
Subjects:
aortic dissection
biomarker
lysophosphatidic acid
diagnosis
chest pain
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2021.789992/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2021.789992/full

Similar Items